James F. Daniel

932 total citations
26 papers, 319 citations indexed

About

James F. Daniel is a scholar working on Surgery, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James F. Daniel has authored 26 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Epidemiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James F. Daniel's work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Microscopic Colitis (3 papers). James F. Daniel is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Microscopic Colitis (3 papers). James F. Daniel collaborates with scholars based in United States, United Kingdom and Germany. James F. Daniel's co-authors include Craig A. Friesen, Charles C. Roberts, Julio Raya, Gregory L. Kearns, Ryan T. Fischer, Ellen Carpenter, Lei Shao, Kimberly A. Horii, Amy J. Nopper and Jeffrey Paul and has published in prestigious journals such as Gastroenterology, Scientific Reports and Anesthesiology.

In The Last Decade

James F. Daniel

25 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James F. Daniel United States 11 122 74 60 52 46 26 319
Dragana Mijač Serbia 12 145 1.2× 137 1.9× 127 2.1× 40 0.8× 12 0.3× 29 423
C Smyth Ireland 9 110 0.9× 61 0.8× 121 2.0× 13 0.3× 16 0.3× 21 377
Yusuf Usta Türkiye 9 66 0.5× 46 0.6× 42 0.7× 21 0.4× 8 0.2× 25 263
İnci̇ Süleymanlar Türkiye 10 124 1.0× 90 1.2× 59 1.0× 32 0.6× 5 0.1× 22 286
Marcin Januszkiewicz Poland 5 85 0.7× 62 0.8× 25 0.4× 34 0.7× 6 0.1× 6 346
Mehrdad Kashifard Iran 9 100 0.8× 67 0.9× 96 1.6× 48 0.9× 29 0.6× 27 320
Esther Lamoureux Canada 12 69 0.6× 240 3.2× 33 0.6× 89 1.7× 8 0.2× 19 446
Francesca Invernizzi Italy 8 97 0.8× 71 1.0× 82 1.4× 17 0.3× 16 0.3× 12 379
Vikas Sachdev India 12 332 2.7× 134 1.8× 117 1.9× 56 1.1× 7 0.2× 20 487
Ronald Bremner United Kingdom 5 140 1.1× 116 1.6× 78 1.3× 11 0.2× 19 0.4× 9 354

Countries citing papers authored by James F. Daniel

Since Specialization
Citations

This map shows the geographic impact of James F. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Daniel more than expected).

Fields of papers citing papers by James F. Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Daniel. The network helps show where James F. Daniel may publish in the future.

Co-authorship network of co-authors of James F. Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Daniel. A scholar is included among the top collaborators of James F. Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Daniel. James F. Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vandriel, Shannon M., Claudia Quammie, Eberhard Lurz, et al.. (2025). Frailty in Pediatric Liver Disease May Be Associated With an Increased Incidence of Readmissions After Pediatric Liver Transplantation. Pediatric Transplantation. 29(3). e70077–e70077.
2.
Slowik, Voytek, et al.. (2022). Use and safety of prophylactic endoscopy from a single center serving urban and rural children with portal hypertension. Scientific Reports. 12(1). 25–25. 6 indexed citations
3.
Sherman, Ashley, et al.. (2022). The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease. Clinical and Translational Science. 15(9). 2241–2250. 2 indexed citations
4.
Mieli‐Vergani, Giorgina, Sanjay Bansal, James F. Daniel, et al.. (2021). Peginterferon Alfa‐2a (40KD) Plus Lamivudine or Entecavir in Children With Immune‐Tolerant Chronic Hepatitis B. Journal of Pediatric Gastroenterology and Nutrition. 73(2). 156–160. 9 indexed citations
5.
Taylor, Sarah A., Veena Venkat, Ronen Arnon, et al.. (2021). Organ‐Specific Comorbidities Are Associated With Distinct Complications After Liver Transplantation for Biliary Atresia. Liver Transplantation. 28(5). 855–866. 1 indexed citations
6.
Fischer, Ryan T., et al.. (2020). Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary disease. Pediatric Transplantation. 24(8). e13807–e13807. 3 indexed citations
7.
8.
Andrews, Walter S., James F. Daniel, Ryan T. Fischer, et al.. (2020). Conservative Management of Pneumatosis Intestinalis and Portal Venous Gas After Pediatric Liver Transplantation. Transplantation Proceedings. 52(3). 938–942. 1 indexed citations
9.
10.
Sandritter, Tracy, et al.. (2019). An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children. Scientific Reports. 9(1). 18090–18090. 10 indexed citations
11.
Sujka, Joseph, Katherine W. Gonzalez, James F. Daniel, et al.. (2018). The impact of thromboelastography on resuscitation in pediatric liver transplantation. Pediatric Transplantation. 22(4). e13176–e13176. 11 indexed citations
12.
Maddux, Michele H., et al.. (2018). Practice survey: adherence monitoring and intervention in pediatric gastroenterology and hepatology. Therapeutics and Clinical Risk Management. Volume 14. 1227–1234. 1 indexed citations
13.
Shakhnovich, Valentina, Carrie A. Vyhlidal, Craig A. Friesen, et al.. (2016). Decreased Pregnane X Receptor Expression in Children with Active Crohn’s Disease. Drug Metabolism and Disposition. 44(7). 1066–1069. 21 indexed citations
14.
Butler, David, et al.. (2015). Bone marrow transplant for X‐linked protoporphyria with severe hepatic fibrosis. Pediatric Transplantation. 19(4). E106–10. 8 indexed citations
15.
Friesen, Craig A., James F. Daniel, Jennifer V. Schurman, et al.. (2011). Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia. BMC Research Notes. 4(1). 322–322. 14 indexed citations
16.
Horii, Kimberly A., et al.. (2008). Disseminated juvenile xanthogranulomatosis in a newborn resulting in liver transplantation. Journal of the American Academy of Dermatology. 58(2). S12–S15. 24 indexed citations
17.
Kearns, Gregory L., Jeffrey L. Blumer, Stephen M. Schexnayder, et al.. (2008). Single‐Dose Pharmacokinetics of Oral and Intravenous Pantoprazole in Children and Adolescents. The Journal of Clinical Pharmacology. 48(11). 1356–1365. 32 indexed citations
18.
Rau, Beate, et al.. (2006). Gallbladder wall inflammatory cells in pediatric patients with biliary dyskinesia and cholelithiasis: a pilot study. Journal of Pediatric Surgery. 41(9). 1545–1548. 18 indexed citations
19.
Friesen, Craig A., et al.. (2004). Safety of Infliximab Treatment in Pediatric Patients with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 39(3). 265–269. 2 indexed citations
20.
Friesen, Craig A., et al.. (2004). Safety of Infliximab Treatment in Pediatric Patients with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 39(3). 265–269. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dragana Mijač Breakdown of academic impact, for papers by C Smyth Breakdown of academic impact, for papers by Yusuf Usta Breakdown of academic impact, for papers by İnci̇ Süleymanlar Breakdown of academic impact, for papers by Marcin Januszkiewicz Breakdown of academic impact, for papers by Mehrdad Kashifard Breakdown of academic impact, for papers by Esther Lamoureux Breakdown of academic impact, for papers by Francesca Invernizzi Breakdown of academic impact, for papers by Vikas Sachdev Breakdown of academic impact, for papers by Ronald Bremner
Rankless by CCL
2026